Gene Query: IGHG2

Dataset Description Geneva Score
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 115.82
Anti-inflammatory effect of indoleacrylic acid (IA) 102.01
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 87.89
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 87.89
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 71.15
Transcriptome analysis reveals differential splicing events in IPF lung tissue 68.95
Primate transcript and protein expression levels evolve under compensatory selection pressures 61.38
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 58.99
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 58.85
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 58.85
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 58.12
Transcriptional profiles of normal human mature B cells 57.6
Gene expression profiling of papillary thyroid cancer from central and invasive regions 52.93
Characterization of the Merkel cell carcinoma miRNome 44.53
RNA-seq of stable and unstable section of human atherosclerotic plaques 44.49
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 43.82
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 43.82
Landscape of H3K4me3 in human CD19 cells 43.42
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 40.29
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 38.55
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 36.41
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 35.68
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 34.81
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 33.93
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 33.63
RNA-sequencing of formalin fixed human primary melanoma tissue 32.3
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 32.13
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 31.96
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 31.4
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 31.4
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 30.43
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 30.43
Fibroblasts in cholesteatoma activate osteoclasts. 30.36
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 29.92
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 29.69
BACH2 in human plasma cell fate decision 29.44
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 29.13
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 28.76
CircRNAome diversity in human mature B-cells, T-cells and monocytes 28.08
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 27.89
The evolution of N6-methyladenosine in primates 27.68
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 27.06
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 26.65
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 26.65
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 26.5
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 25.08
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 25.02
An acquired vulnerability of drug resistant melanoma with therapeutic potential 24.94
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 24.94
RNA-seq data from human lymphoma cell lines 23.74
ChIP-seq and RNA-seq from human lymphoma cell lines 23.74
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 23.35
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 22.79
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 22.62
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 22.62
Human optic chiasm from healthy controls and multiple sclerosis patients 21.57
Multiple sclerosis and EAE 21.57
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 20.92
The Genetic Landscape of Diamond-Blackfan Anemia 20.74
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 20.71
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 20.7
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 20.03
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 19.87
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 19.71
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 19.59
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 19.59
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 19.34
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 19.07
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 18.44
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 18.43
A practical evaluation of alignment algorithms for RNA variant calling analysis 18.05
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 17.69
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 17.64
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 17.52
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 17.49
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 17.49
Be1 and Be2 B cells are transcriptionally distinct 17.14
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 16.51
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 16.4
RNA expression profiles comparing primary and omental ovarian carcinoma samples 16.08
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 15.94
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 15.91
Transcriptome of human white and brown adipose tissue biopsies 14.7
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 14.17
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 13.97
Defective structural RNA processing in relapsing-remitting multiple sclerosis 13.89
LncRNA expression profiling of ischemic stroke patients 13.57
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 13.49
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 13.49
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 13.08
Bone marrow derived human B cells [normal proB] 13.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 12.91
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 12.91
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 12.88
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 12.83
ML29755 RNA-seq data 12.35
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 12.04
Non-coding regions are the main source of tumor-specific antigens 11.88
Non-coding regions are the main source of tumor-specific antigens [human] 11.88
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 11.75
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 11.51
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 11.5
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 10.94
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 10.94
quanTIseq: quantifying immune contexture of human tumors 10.83
Human T-cell lymphoblastic lymphoma samples and control thymuses 10.81
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 10.81
Dysregulated immune system networks in war veterans with PTSD 10.8
Transcriptome Profiling of Human Primary Monocytes 10.68
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 10.52
Frailty in middle age is associated with race-specific changes to the transcriptome. 10.4
circRNA profile in hypopharyngeal cancer 10.08
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 10.0
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 9.97
The gene expression profiles of gallbladder cancer 9.96
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 9.95
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 9.86
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 9.56
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 9.56
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 9.35
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 8.9
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 8.87
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 8.85
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 8.66
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 8.46
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 8.35
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 8.32
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 8.2
The role of m6A/m-RNA methylation in stress response regulation 8.2
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 8.17
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 8.0
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 7.9
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 7.83
Noncoding regions are the main source of targetable tumor-specific antigens 7.73
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 7.68
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 7.67
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.63
Transcriptome analysis of CNS leukemia 7.52
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 7.52
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 7.47
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 7.46
Characterization of human ILC2 subsets 7.46
Leucegene: AML sequencing (part 6) 7.26
mRNA-sequencing of breast cancer subtypes and normal tissue 7.23
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 7.19
Polarized B -cell functions 7.16
Leucegene: ALL sequencing 7.04
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 7.02
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.94
Widespread intronic polyadenylation diversifies immune cell transcriptomes 6.91
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 6.87
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.85
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 6.65
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 6.35
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 6.3
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 6.26
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 6.18
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 6.18
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 6.17
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 6.05
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 6.04
Molecular analysis of renal cell carcinoma with unclassfied histology 6.04
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 5.99
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 5.96
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 5.95
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 5.85
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 5.65
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 5.65
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 5.62
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 5.54
Evaluating pre-clinical models for studying NASH driven HCC. 5.5
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 5.42
RNAseq analysis of ruxolitinib treated breast cancers 5.38
Gene expression profiling in metabolically heterogeneous human lung tumors 5.34
The DNA methylation landscape of human melanoma 5.33
The DNA methylation landscape of human melanoma [RNA-Seq] 5.33
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 5.31
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 5.29
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 5.23
RNA-seq melanoma 5.22
Universal alternative splicing of noncoding exons 5.17
Zone dependent distinctive gene expression profile of the normal human liver tissue 5.16
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.15
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 5.13
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.09
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 4.97
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.96
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 4.9
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 4.9
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 4.88
An optimization system for isolating and sequencing of single human colon cancer cells 4.87
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 4.85
RNA-seq of primary patient AML samples 4.83
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 4.82
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 4.72
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 4.68
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.67
Primary Human B-cell Temporal Response to CD40L Stimulation 4.59
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 4.5
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 4.48
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.43
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.43
RNA-Seq analysis of human colorectal cancer with liver metastasis 4.43
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.33
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.27
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.26
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 4.26
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 4.2
The expression profiles of GBC liver metastasis 4.19
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 4.13
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.13
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.11
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 4.1
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 4.04
Specific molecular signatures underlie response to decitabine in CMML 4.04
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 4.04
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 4.04
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 4.01
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.97
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 3.91
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 3.83
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 3.81
Hepatosplenic T cell lymphoma 3.79
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 3.79
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.74
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.7
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.69
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 3.66
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 3.66
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 3.55
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 3.55
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.5
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.5
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 3.46
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.43
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 3.41
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 3.38
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.37
Transcriptional profile in human S. haematobium infection 3.37
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 3.36
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 3.36
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.34
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.32
Expression patterns in chronic thromboembolic pulmonary hypertension 3.31
Single cell transcriptome of peritoneal cells 3.29
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 3.27
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 3.27
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 3.19
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 3.14
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.14
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 3.13
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.08
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 3.02
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.0
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.93
RNA Sequencing of three pairs of gastric cancer 2.83
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.81
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 2.77
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 2.77
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 2.76
RNA-sequencing 2.75
RNA-seq in endometrial stromal tumors 2.74
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 2.73
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 2.72
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 2.62
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.61
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.59
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.59
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.54
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.51
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.43
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 2.42
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 2.4
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 2.4
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.39
RNA-Seq and expression data from human adipose tissue 2.37
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.37
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.33
Hepatic transcriptome of pediatric hepatoblastoma. 2.33
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 2.3
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.29
A single cell reference map for human blood and tissue T cell activation 2.28
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 2.27
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 2.27
Neonatal and adult human testis defined at the single-cell level 2.25
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.22
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 2.16
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.12
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.12
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.11
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.11
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 2.1
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 2.1
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 2.08
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 2.04
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 2.03
Hepatocyte maturation 2.02
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 1.97
Nonpregnant and term pregnant human myometrial tissues 1.97
Measure transcript integrity using RNA-seq data 1.94
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.94
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.94
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.91
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.88
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.86
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.86
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.85
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.84
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 1.82
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 1.82
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.79
Transcriptomic analysis of frontal fibrosing alopecia 1.79
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.77
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 1.76
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.72
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.71
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.71
Gene expression activation in CLL mediated by MSCs contact 1.7
RNA-Seq from human ILC transitional populations 1.69
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.69
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.68
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.65
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.65
Identification of expressed and conserved human non-coding RNAs 1.63
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.62
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.62
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 1.6
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 1.6
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.6
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.56
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 1.56
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 1.56
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.55
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 1.55
Landscape and variation of RNA secondary structure across the human transcriptome 1.52
Total RNA-Seq data from leukemic patients with complex structural variants 1.51
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.5
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.5
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 1.5
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.5
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.5
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.47
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.44
Generation and functional characterization of MDSC-like cells 1.43
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.42
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.42
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.39
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.38
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 1.31
MYC dependent mRNA translation shapes gene expression and cell biology 1.31
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.29
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.28
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.27
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.25
Intron retention induced by microsatellite expansions as a disease biomarker. 1.22
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.2
Expression and functions of long noncoding RNAs during human T helper cell differentiation 1.18
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.18
Expression analysis of the TAF1 syndrome 1.17
Gene expression of collecting duct carcinoma of the kidney 1.15
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.14
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.14
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 1.14
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 1.13
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.11
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.11
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 1.08
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.05
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.05
MHC Transcriptomic landscape at haplotype-specific resolution 1.04
Aortic Valve Tissue: Stenosis vs. Sclerosis 1.04
Gene expression analysis of human adenomas. 1.04
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.01
Ro60-knockout cells 1.01
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.98
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 0.98
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.94
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.93
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.93
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 0.9
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.88
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.86
Gene expression analysis of human liver progenitor-like cells in culture 0.86
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.85
Trans-differentiation of human adult peripheral blood T cells into neurons 0.82
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 0.78
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 0.78
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.76
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 0.76
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.73
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.73
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.71
The Genomic Landscape of Atypical Fibroxanthoma 0.7
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.68
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.67
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.67
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.66
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.66
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.65
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.64
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.63
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 0.63
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.62
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.62
Dermal endothelial cells of type 2 diabetic patients 0.6
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.6
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.6
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 0.6
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.58
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.58
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.58
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 0.57
Global analysis of alternative splicing regulated by RBM10 0.57
The transcriptome of Kawasaki Disease arteritis 0.54
Aging-associated patterns in the expression of human endogenous retroviruses 0.54
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 0.54
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.54
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.51
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.51
CUREfast: Accelerating research with families 0.47
mRNA expression profile of Lymphocytes 0.44
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.43
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.43
Gene expression analysis of human hepatocellular cancers 0.41
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.41
RNA-sequencing of human liver tissue 0.41
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.39
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.38
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.38
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.37
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.37
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.35
RNA-seq data 0.34
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.34
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.34
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.34
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.34
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.34
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.34
Reprogrammed myeloid cell transcriptomes in NSCLC 0.33
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.33
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.33
The Glioma-Infiltrating T Cell Receptor Repertoire 0.32
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 0.32
CD86 regulates a pro-survival signal in myeloma cells 0.3
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.29
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.29
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.28
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.28
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.26
Gene expression profile difference among renal location in a stone former 0.26
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.25
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 0.24
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.24
naive T cell heterogeneity after neonatal thymectomy 0.24
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 0.23
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 0.23
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.22
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.22
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 0.22
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.21
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.21
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 0.21
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.2
RNA sequencing of T-ALL (COG study) 0.2
Analyses of T-ALL (COG study) 0.2
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 0.2
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.19
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.19
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.19
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.19
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.19
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.17
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.17
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.17
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.16
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.16
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.15
Clinker: visualizing fusion genes detected in RNA-seq data 0.15
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.14
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.12
Common inflammatory pathways between NEC and Crohn's disease 0.11
NAPRT activation of macrophages 0.11
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.11
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 0.1
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.09
RNA Seq of Alagille liver biopsies 0.09
Alagille_Nodder 0.09
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.07
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.07
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.07
CD74 role in transcription regulation [RNA-seq] 0.05
CD74 role in transcription regulation 0.05
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 0.03
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.03
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.02
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.02
Tpl-2 and MEK small molecule inhibitors 0.02
Tpl-2 small molecule project 0.02
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation